Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 7.15Cr 6.25Cr 5.76Cr 5.31Cr 10Cr 688.36Cr 10Cr 69Cr 27Cr 337.13Cr 27Cr 26Cr 1.16TCr | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 6.24Cr 5.45Cr 5.03Cr 4.63Cr 8.74Cr 600.49Cr 8.93Cr 60Cr 24Cr 294.1Cr 23Cr 23Cr 1.01TCr | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
93.75% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 7.15Cr | ||
| -1.29% | -3.11% | -0.35% | +2.64% | 4.92TCr | ||
| +3.90% | -0.39% | +386.06% | +588.97% | 3.96TCr | ||
| -1.70% | +4.46% | +5.93% | +61.54% | 3.47TCr | ||
| -2.01% | -0.76% | +28.41% | -8.52% | 3.44TCr | ||
| +0.06% | +0.34% | +2.38% | +34.47% | 2.71TCr | ||
| +0.46% | -3.49% | - | - | 1.62TCr | ||
| -0.04% | -0.09% | +72.42% | +116.45% | 1.54TCr | ||
| +1.12% | +1.91% | +14.54% | +15.44% | 1.41TCr | ||
| 0.00% | +1.36% | +18.43% | -31.23% | 1.3TCr | ||
| Average | -0.71% | +0.03% | +65.98% | +97.47% | 2.71TCr | |
| Weighted average by Cap. | -0.06% | -0.18% | +79.44% | +122.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.24L 14.19L 13.09L 12.07L 22.75L 16Cr 23.25L 1.57Cr 61.56L 7.66Cr 60.98L 59.64L 26Cr | 1L 1L 1L 93.12T 2L 1.21Cr 2L 12.08L 5L 59.09L 5L 5L 2.03Cr |
| Net income | -1.27Cr -1.11Cr -1.02Cr -94.14L -1.77Cr -121.96Cr -1.81Cr -12Cr -4.8Cr -60Cr -4.76Cr -4.65Cr -205.62Cr | -23Cr -20Cr -19Cr -17Cr -33Cr -2.24TCr -33Cr -224.67Cr -88Cr -1.1TCr -88Cr -86Cr -3.78TCr |
| Net Debt | 13.96L 12.2L 11.26L 10.38L 19.56L 13Cr 20L 1.35Cr 52.94L 6.59Cr 52.44L 51.29L 23Cr | -91.25L -79.74L -73.58L -67.82L -1.28Cr -88Cr -1.31Cr -8.79Cr -3.46Cr -43Cr -3.43Cr -3.35Cr -148.15Cr |
Employees
-

















